The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Apoptosis and Molecular Targeting Therapy in Cancer
Hassan, M., Watari, H., AbuAlmaaty, A., Ohba, Y., & Sakuragi, N. (2014) · BioMed Research International · doi:10.1155/2014/150845 · Cited by 1,121
RetractedRETRACTED: hnRNP K: An HDM2 Target and Transcriptional Coactivator of p53 in Response to DNA Damage
Moumen, A., Masterson, P., O'Connor, M. J., & Jackson, S. P. (2005) · Cell · doi:10.1016/j.cell.2005.09.032 · Cited by 350
RetractedApoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853
Apoptosis in cancer: from pathogenesis to treatment
Wong, R. S. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-87 · Cited by 2,836
Mitochondria and cell death: outer membrane permeabilization and beyond
Tait, S. W. G., & Green, D. R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2952 · Cited by 2,593
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
Fulda, S., & Debatin, K.-M. (2006) · Oncogene · doi:10.1038/sj.onc.1209608 · Cited by 2,312
Kruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610
Chipuk, J. E., Moldoveanu, T., Llambi, F., Parsons, M. J., & Green, D. R. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.025 · Cited by 1,427
Bim: a novel member of the Bcl-2 family that promotes apoptosis
O'Connor, L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.384 · Cited by 1,166
The SR protein family of splicing factors: master regulators of gene expression
Long, J. C., & Caceres, J. F. (2009) · Biochemical Journal · doi:10.1042/bj20081501 · Cited by 1,137
Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas Molecule
Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J., & Mountz, J. D. (1994) · Science · doi:10.1126/science.7510905 · Cited by 1,107
Caspases in apoptosis and beyond
Li, J., & Yuan, J. (2008) · Oncogene · doi:10.1038/onc.2008.297 · Cited by 1,090
Context-dependent control of alternative splicing by RNA-binding proteins
Fu, X.-D., & Ares, M. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3778 · Cited by 1,044
The gene encoding the splicing factor SF2/ASF is a proto-oncogene
Karni, R., de Stanchina, E., Lowe, S. W., Sinha, R., Mu, D., & Krainer, A. R. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1209 · Cited by 934
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
David, C. J., & Manley, J. L. (2010) · Genes & Development · doi:10.1101/gad.1973010 · Cited by 814
Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
Mita, A. C., Mita, M. M., Nawrocki, S. T., & Giles, F. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0746 · Cited by 765
Mechanisms of Action of Bcl-2 Family Proteins
Shamas-Din, A., Kale, J., Leber, B., & Andrews, D. W. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008714 · Cited by 705
Bcl-xL Retrotranslocates Bax from the Mitochondria into the Cytosol
Edlich, F., Banerjee, S., Suzuki, M., Cleland, M. M., Arnoult, D., Wang, C., Neutzner, A., Tjandra, N., & Youle, R. J. (2011) · Cell · doi:10.1016/j.cell.2011.02.034 · Cited by 630
Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias.
Tamm, I., Kornblau, S. M., Segall, H., Krajewski, S., Welsh, K., Kitada, S., Scudiero, D. A., Tudor, G., Qui, Y. H., Monks, A. P., et al. (2000) · PubMed · Cited by 620
Fulda, S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24064 · Cited by 615
Fernald, K., & Kurokawa, M. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.07.006 · Cited by 579
Krueger, A., Schmitz, I., Baumann, S., Krammer, P. H., & Kirchhoff, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101780200 · Cited by 566
Ng, K. P., Hillmer, A. M., Chuah, C. T. H., Juan, W. C., Ko, T. K., Teo, A. S. M., Ariyaratne, P. N., Takahashi, N., Sawada, K., Fei, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2713 · Cited by 557
Mcl‐1; the molecular regulation of protein function
Thomas, L. W., Lam, C., & Edwards, S. W. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.05.061 · Cited by 538
Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes
Sveen, A., Kilpinen, S., Ruusulehto, A., Lothe, R. A., & Skotheim, R. I. (2016) · Oncogene · doi:10.1038/onc.2015.318 · Cited by 470
Survivin, a cancer target with an emerging role in normal adult tissues
Fukuda, S., & Pelus, L. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0375 · Cited by 465
Degradation of chromosomal DNA during apoptosis
Nagata, S., Nagase, H., Kawane, K., Mukae, N., & Fukuyama, H. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401161 · Cited by 458
Anczuków, O., Rosenberg, A. Z., Akerman, M., Das, S., Zhan, L., Karni, R., Muthuswamy, S. K., & Krainer, A. R. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2207 · Cited by 447
BCL-2 Family Proteins: Critical Checkpoints of Apoptotic Cell Death
Danial, N. N. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1598 · Cited by 433
The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer
Stewart, M. L., Fire, E., Keating, A. E., & Walensky, L. D. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.391 · Cited by 418
An informatics approach identifying markers of chemosensitivity in human cancer cell lines.
Amundson, S. A., Myers, T. G., Scudiero, D. A., Kitada, S., Reed, J. C., & Fornace, A. J. (2000) · PubMed · Cited by 408
Evolution of SR protein and hnRNP splicing regulatory factors
Busch, A., & Hertel, K. J. (2012) · WIREs RNA · doi:10.1002/wrna.100 · Cited by 394
Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
Shim, J. S., & Liu, J. O. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.9224 · Cited by 382
Structure-guided design of a selective BCL-XL inhibitor
Lessene, G., Czabotar, P. E., Sleebs, B. E., Zobel, K., Lowes, K. N., Adams, J. M., Baell, J. B., Colman, P. M., Deshayes, K., Fairbrother, W. J., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1246 · Cited by 381
Regulation of Fas Alternative Splicing by Antagonistic Effects of TIA-1 and PTB on Exon Definition
Izquierdo, J. M., Majós, N., Bonnal, S., Martínez, C., Castelo, R., Guigó, R., Bilbao, D., & Valcárcel, J. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.015 · Cited by 364
The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x
Paronetto, M. P., Achsel, T., Massiello, A., Chalfant, C. E., & Sette, C. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200701005 · Cited by 334
An Alternative Splicing Network Links Cell-Cycle Control to Apoptosis
Moore, M. J., Wang, Q., Kennedy, C. J., & Silver, P. A. (2010) · Cell · doi:10.1016/j.cell.2010.07.019 · Cited by 316
Bcl-XL Inhibits Membrane Permeabilization by Competing with Bax
Billen, L. P., Kokoski, C. L., Lovell, J. F., Leber, B., & Andrews, D. W. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060147 · Cited by 314
Aberrant RNA Splicing in Cancer
Escobar-Hoyos, L., Knorr, K., & Abdel-Wahab, O. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050407 · Cited by 302
Bae, J., Leo, C. P., Hsu, S. Y., & Hsueh, A. J. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909826199 · Cited by 289
c-FLIP, a master anti-apoptotic regulator.
Safa, A. R. (2012) · PubMed · Cited by 272
Regulation of Alternative Splicing by Reversible Protein Phosphorylation
Stamm, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r700034200 · Cited by 251
Targeting p53 for Novel Anticancer Therapy
Wang, Z., & Sun, Y. (2010) · Translational Oncology · doi:10.1593/tlo.09250 · Cited by 250
The RNAissance family: SR proteins as multifaceted regulators of gene expression
Howard, J. M., & Sanford, J. R. (2015) · WIREs RNA · doi:10.1002/wrna.1260 · Cited by 247
Obexer, P., & Ausserlechner, M. J. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00197 · Cited by 244
Golan-Gerstl, R., Cohen, M., Shilo, A., Suh, S.-S., Bakàcs, A., Coppola, L., & Karni, R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4410 · Cited by 232
BH3-only proteins and their roles in programmed cell death
Giam, M., Huang, D. C. S., & Bouillet, P. (2008) · Oncogene · doi:10.1038/onc.2009.50 · Cited by 229
Wang, Y., Chen, D., Qian, H., Tsai, Y. S., Shao, S., Liu, Q., Dominguez, D., & Wang, Z. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.010 · Cited by 225
Regulation of DNA fragmentation: the role of caspases and phosphorylation
Kitazumi, I., & Tsukahara, M. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07975.x · Cited by 223
Extrinsic and Intrinsic Apoptosis Signal Pathway Review
Hongmei, Z. (2012) · InTech eBooks · doi:10.5772/50129 · Cited by 220
Hong, D. S., Kurzrock, R., Naing, A., Wheler, J. J., Falchook, G. S., Schiffman, J. S., Faulkner, N., Pilat, M. J., O’Brien, J., & LoRusso, P. (2014) · Investigational New Drugs · doi:10.1007/s10637-013-0046-5 · Cited by 219
Garneau, D., Revil, T., Fisette, J.-F., & Chabot, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501070200 · Cited by 218
SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance
Jia, R., Li, C., McCoy, J. P., Deng, C.-X., & Zheng, Z.-M. (2010) · International Journal of Biological Sciences · doi:10.7150/ijbs.6.806 · Cited by 206
Targeting Mcl-1 for the therapy of cancer
Quinn, B. A., Dash, R., Azab, B., Sarkar, S., Das, S. K., Kumar, S., Oyesanya, R. A., Dasgupta, S., Dent, P., Grant, S., et al. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.609167 · Cited by 202
A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation
Notari, M., Neviani, P., Santhanam, R., Blaser, B. W., Chang, J.-S., Galietta, A., Willis, A. E., Roy, D. C., Caligiuri, M. A., Marcucci, G., et al. (2006) · Blood · doi:10.1182/blood-2005-09-3732 · Cited by 202
The interplay between the Bcl-2 family and death receptor-mediated apoptosis
Sprick, M. R., & Walczak, H. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.11.002 · Cited by 201
Live and let die: regulatory mechanisms in Fas-mediated apoptosis
Curtin, J. F., & Cotter, T. G. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(03)00093-7 · Cited by 200
Survivin splice variants regulate the balance between proliferation and cell death
Caldas, H., Jiang, Y., Holloway, M. P., Fangusaro, J., Mahotka, C., Conway, E. M., & Altura, R. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208350 · Cited by 199
Complicating the complexity of p53
Yee, K. S., & Vousden, K. H. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi122 · Cited by 188
Caspase activation pathways: some recent progress
Cullen, S. P., & Martin, S. J. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.59 · Cited by 187
Cellular FLICE-Like Inhibitory Protein (C-FLIP): A Novel Target for Cancer Therapy
Safa, A., Day, T., & Wu, C.-H. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908783497087 · Cited by 184
A Caspase-9 Variant Missing the Catalytic Site Is an Endogenous Inhibitor of Apoptosis
Seol, D.-W., & Billiar, T. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2072 · Cited by 179
Decorsière, A., Cayrel, A., Vagner, S., & Millevoi, S. (2011) · Genes & Development · doi:10.1101/gad.607011 · Cited by 177
The RNA Splicing Response to DNA Damage
Shkreta, L., & Chabot, B. (2015) · Biomolecules · doi:10.3390/biom5042935 · Cited by 174
Enge, M., Bao, W., Hedström, E., Jackson, S. P., Moumen, A., & Selivanova, G. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.019 · Cited by 171
Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy
Safa, A. R., & Pollok, K. E. (2011) · Cancers · doi:10.3390/cancers3021639 · Cited by 167
Tang, Y., Horikawa, I., Ajiro, M., Robles, A. I., Fujita, K., Mondal, A. M., Stauffer, J. K., Zheng, Z.-M., & Harris, C. C. (2013) · Oncogene · doi:10.1038/onc.2012.288 · Cited by 165
Holčík, M., Gordon, B. W., & Korneluk, R. G. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.280-288.2003 · Cited by 164
Phosphorylation-Mediated Regulation of Alternative Splicing in Cancer
Naro, C., & Sette, C. (2013) · International Journal of Cell Biology · doi:10.1155/2013/151839 · Cited by 164
Gout, S., Brambilla, E. M., Boudria, A., Drissi, R., Lantuéjoul, S., Gazzéri, S., & Eymin, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046539 · Cited by 163
Modification of Alternative Splicing of Bcl-x Pre-mRNA in Prostate and Breast Cancer Cells
Mercatante, D. R., Bortner, C. D., Cidlowski, J. A., & Kole, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009256200 · Cited by 163
Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas
LeFave, C. V., Squatrito, M., Vorlová, S., Rocco, G., Brennan, C., Holland, E. C., Pan, Y., & Cartegni, L. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.259 · Cited by 160
The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers
Cohen‐Eliav, M., Golan‐Gerstl, R., Siegfried, Z., Andersen, C. L., Thorsen, K., Orntoft, T. F., Mu, D., & Karni, R. (2012) · The Journal of Pathology · doi:10.1002/path.4129 · Cited by 159
Xiao, R., Sun, Y., Ding, J.-H., Lin, S., Rose, D. W., Rosenfeld, M. G., Fu, X.-D., & Li, X. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00288-07 · Cited by 159
Small Molecule Modulators of Pre-mRNA Splicing in Cancer Therapy
Salton, M., & Misteli, T. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.11.005 · Cited by 159
Multiple and Specific mRNA Processing Targets for the Major Human hnRNP Proteins
Venables, J. P., Koh, C.-S., Froehlich, U., Lapointe, E., Couture, S., Inkel, L., Bramard, A., Paquet, E. R., Watier, V., Durand, M., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00726-08 · Cited by 158
Cammas, A., Pileur, F., Bonnal, S., Lewis, S. M., Lévêque, N., Holčík, M., & Vagner, S. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-06-0603 · Cited by 158
Srinivasula, S. M., Ahmad, M., Guo, Y., et al. (1999) · PubMed · Cited by 157
Mitchell, S. A., Brown, E. C., Coldwell, M. J., Jackson, R. J., & Willis, A. E. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3364-3374.2001 · Cited by 153
Caspase-8 as a therapeutic target in cancer
Stupack, D. G. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.07.022 · Cited by 152
Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin
Edmond, V., Moysan, E., Khochbin, S., Matthias, P., Brambilla, C., Brambilla, E. M., Gazzéri, S., & Eymin, B. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.333 · Cited by 151
Li, X., Wang, J., & Manley, J. L. (2005) · Genes & Development · doi:10.1101/gad.1359305 · Cited by 145
Jia, L., Srinivasula, S. M., Liu, F., Newland, A. C., Fernandes‐Alnemri, T., Alnemri, E. S., & Kelsey, S. M. (2001) · Blood · doi:10.1182/blood.v98.2.414 · Cited by 143
Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors
Jiang, Z., Zhang, W., Rao, Y., & Wu, J. Y. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9155 · Cited by 143
Inhibitor of apoptosis proteins and apoptosis
Wei, Y., Fan, T., & Yu, M. (2008) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2008.00407.x · Cited by 143
Caspase 2 in apoptosis, the DNA damage response and tumour suppression: enigma no more?
Kumar, S. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2745 · Cited by 142
Adesso, L., Calabretta, S., Barbagallo, F., Capurso, G., Pilozzi, E., Geremia, R., Fave, G. D., & Sette, C. (2012) · Oncogene · doi:10.1038/onc.2012.306 · Cited by 141
Shultz, J. C., Goehe, R. W., Wijesinghe, D. S., Murudkar, C. S., Hawkins, A. J., Shay, J. W., Minna, J. D., & Chalfant, C. E. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1545 · Cited by 132
Splicing-Factor Oncoprotein SRSF1 Stabilizes p53 via RPL5 and Induces Cellular Senescence
Fregoso, O. I., Das, S., Akerman, M., & Krainer, A. R. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.001 · Cited by 130
Goehe, R. W., Shultz, J. C., Murudkar, C. S., Usanovic, S., Lamour, N. F., Massey, D. H., Zhang, L., Camidge, D. R., Shay, J. W., Minna, J. D., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43552 · Cited by 129
Iervolino, A., Santilli, G., Trotta, R., Guerzoni, C., Cesi, V., Bergamaschi, A., Gambacorti-Passerini, C. B., Calabretta, B., & Perrotti, D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2255-2266.2002 · Cited by 122
Gonçalves, V., Matos, P., & Jordan, P. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp317 · Cited by 116
Subcellular Relocalization of a Trans -acting Factor Regulates XIAP IRES-dependent Translation
Lewis, S. M., Veyrier, A., Ungureanu, N. H., Bonnal, S., Vagner, S., & Holčı́k, M. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-06-0515 · Cited by 116
Targeting the Apoptosome for Cancer Therapy
Ledgerwood, E. C., & Morison, I. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1172 · Cited by 114
Ma, K., He, Y., Zhang, H., Fei, Q., Niu, D., Wang, D., Ding, X., Xu, H., Chen, X., & Zhu, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.291229 · Cited by 113
Merdzhanova, G., Edmond, V., Seranno, S. D., Broeck, A. V. D., Corcos, L., Brambilla, C., Brambilla, E. M., Gazzéri, S., & Eymin, B. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.135 · Cited by 113
Wu, G. S., & Ding, Z. (2002) · Oncogene · doi:10.1038/sj.onc.1205020 · Cited by 113
Big wheel keeps on turning: apoptosome regulation and its role in chemoresistance
Fadeel, B., Ottosson, A., & Pervaiz, S. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402265 · Cited by 107
Kurokawa, K., Akaike, Y., Masuda, K., Kuwano, Y., Nishida, K., Yamagishi, N., Kajita, K., Tanahashi, T., & Rokutan, K. (2013) · Oncogene · doi:10.1038/onc.2013.86 · Cited by 106
Siqueira, R. P., Barbosa, É. D. A. A., Polêto, M. D., Righetto, G. L., Seraphim, T. V., Salgado, R. L., Ferreira, J. G., Barros, M. V. D. A., de Oliveira, L. L., Laranjeira, A. B. A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134882 · Cited by 105
Lv, L., Deng, H., Li, Y., Zhang, C., Liu, X., Liu, Q., Zhang, D., Wang, L., Pu, Y., Zhang, H., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.367 · Cited by 105
Marcel, V., Fernandes, K., Terrier, O., Lane, D. P., & Bourdon, J. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.73 · Cited by 105
Jiang, C. C., Lai, F., Tay, K. H., Croft, A. J., Rizos, H., Becker, T. M., Yang, F., Liu, H., Thorne, R. F., Hersey, P., et al. (2010) · Cell Death and Disease · doi:10.1038/cddis.2010.48 · Cited by 104
New insights into p53 activation
Brooks, C. L., & Gu, W. (2010) · Cell Research · doi:10.1038/cr.2010.53 · Cited by 102
Inhibitor of apoptosis proteins and apoptosis
Yunbo, Wei, Tingjun, et al. (2008) · 生物化学与生物物理学报:英文版 · Cited by 102
Shultz, J. C., Goehe, R. W., Murudkar, C. S., Wijesinghe, D. S., Mayton, E. K., Massiello, A., Hawkins, A. J., Mukerjee, P., Pinkerman, R. L., Park, M. A., et al. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0061 · Cited by 95
Bielli, P., Bordi, M., Biasio, V. D., & Sette, C. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku922 · Cited by 95
He, X., Arslan, A. D., Pool, M. D., Ho, T.-T., Darcy, K. M., Coon, J. S., & Beck, W. T. (2010) · Oncogene · doi:10.1038/onc.2010.426 · Cited by 94
hnRNP U Enhances Caspase-9 Splicing and Is Modulated by AKT-dependent Phosphorylation of hnRNP L
Vu, N., Park, M. A., Shultz, J. C., Goehe, R. W., Hoeferlin, L. A., Shultz, M. D., Smith, S. A., Lynch, K. W., & Chalfant, C. E. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.443333 · Cited by 92
Mami, U., Miyashita, T., Shikama, Y., Tadokoro, K., & Yamada, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03145-3 · Cited by 91
Kim, J. H., Park, R., Chen, J., Kim, J., Jeong-Yu, S., & Ohn, T. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.171 · Cited by 91
Kashyap, M. K., Kumar, D., Villa, R., Clair, J. J. L., Benner, C. W., Sasik, R., Jones, H., Ghia, E. M., Rassenti, L. Z., Kipps, T. J., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.122069 · Cited by 91
Himeji, D., Horiuchi, T., Tsukamoto, H., Hayashi, K., Watanabe, T., & Harada, M. (2002) · Blood · doi:10.1182/blood.v99.11.4070 · Cited by 91
Revil, T., Pelletier, J., Toutant, J., Cloutier, A., & Chabot, B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.019711 · Cited by 91
Gammons, M. V. R., Fedorov, O., Ivison, D., Du, C., Clark, T., Hopkins, C., Hagiwara, M., Dick, A. D., Cox, R. J., Harper, S. J., et al. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12422 · Cited by 89
Caffeine Inhibits Cell Proliferation and Regulates PKA/GSK3β Pathways in U87MG Human Glioma Cells
Ku, B. M., Lee, Y. K., Jeong, J. Y., Ryu, J., Choi, J., Kim, J. S., Cho, Y. W., Roh, G. S., Kim, H. J., Cho, G. J., et al. (2011) · Molecules and Cells · doi:10.1007/s10059-011-0027-5 · Cited by 85
Regulation of Mcl-1 by SRSF1 and SRSF5 in Cancer Cells
Gautrey, H., & Tyson-Capper, A. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051497 · Cited by 84
Confirmation of a BRAF mutation‐associated gene expression signature in melanoma
Johansson, P. A., Pavey, S. J., & Hayward, N. K. (2007) · Pigment Cell Research · doi:10.1111/j.1600-0749.2007.00375.x · Cited by 83
Massiello, A., & Chalfant, C. E. (2006) · Journal of Lipid Research · doi:10.1194/jlr.c600003-jlr200 · Cited by 77
Cloutier, P., Toutant, J., Shkreta, L., Goekjian, S. R., Revil, T., & Chabot, B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800353200 · Cited by 75
Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer
Chen, Z., Cai, L., Zhu, J., Chen, M., Chen, J., Li, Z., Liu, X.-D., Wang, S., Bie, P., Jiang, P., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr088 · Cited by 74
Plötz, M., Gillissen, B. F., Hossini, A. M., Daniel, P. T., & Eberle, J. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.71 · Cited by 69
Targeting the anti-apoptotic Bcl-2 family members for the treatment of cancer.
Weyhenmeyer, B., Murphy, Á. C., Prehn, J. H. M., & Murphy, B. M. (2012) · PubMed · Cited by 68
Côté, J., Dupuis, S., & Wu, J. Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008924200 · Cited by 68
Zou, L., Zhang, H., Du, C., Liu, X., Zhu, S., Zhang, W., Li, Z., Gao, C., Zhao, X., Mei, M., et al. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-42 · Cited by 67
Côté, J., Dupuis, S., Jiang, Z., & Wu, J. Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.938 · Cited by 65
Splicing Regulators and Their Roles in Cancer Biology and Therapy
da Silva, M. R., Moreira, G. A., da Silva, R. A. G., Barbosa, É. D. A. A., Siqueira, R. P., Teixeira, R. R., de Almeida, M. R., Silva‐Júnior, A., Fietto, J. L. R., & Bressan, G. C. (2015) · BioMed Research International · doi:10.1155/2015/150514 · Cited by 64
Chang, J., Yang, D.-M., Chang, W.-H., Chow, L., Chan, W.-L., Lin, H.-H., Huang, H.-D., Chang, Y., Hung, C.-H., & Yang, W.-K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018643 · Cited by 63
Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage
Comiskey, D. F., Jacob, A. G., Singh, R. K., Tapia-Santos, A. S., & Chandler, D. S. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv223 · Cited by 62
Chang, W., Liu, T., Yang, W.-K., Lee, C.-C., Lin, Y., Chen, T., & Chang, J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1037 · Cited by 61
Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing
Shkreta, L., Bell, B., Revil, T., Venables, J. P., Prinos, P., Elela, S. A., & Chabot, B. (2013) · Cancer treatment and research · doi:10.1007/978-3-642-31659-3_3 · Cited by 60
Moumen, A., Magill, C. P., Dry, K. L., & Jackson, S. P. (2013) · Cell Cycle · doi:10.4161/cc.23592 · Cited by 60
XIAP as a prognostic marker of early recurrence of nonmuscular invasive bladder cancer
Li, M., Song, T., Yin, Z.-F., & Na, Y.-Q. (2007) · Chinese Medical Journal · doi:10.1097/00029330-200703020-00007 · Cited by 59
Chen, L., Liu, H.-P., Li, H.-P., Hsueh, C., Yu, J., Liang, C.-L., & Chang, Y.-S. (2009) · Oncogene · doi:10.1038/onc.2009.55 · Cited by 57
Liu, J.-W., Chandra, D., Tang, S.-H., Chopra, D. P., & Tang, D. G. (2002) · PubMed · Cited by 56
Gabriel, M., Delforge, Y., Deward, A., Habraken, Y., Hennuy, B., Piette, J. G., Klinck, R., Chabot, B., Colige, A., & Lambert, C. A. (2015) · BMC Cancer · doi:10.1186/s12885-015-1259-0 · Cited by 55
Christian, K. J., Lang, M. A., & Raffalli‐Mathieu, F. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.042507 · Cited by 55
Ezponda, T., Pajares, M. J., Agorreta, J., Echeveste, J. I., López-Picazo, J. M., Torre, W., Pı́o, R., & Montuenga, L. M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0076 · Cited by 55
Aberrant expression of splicing factors in newly diagnosed acute myeloid leukemia
Liu, J., Huang, B., Xiao, Y., Xiong, H.-M., Li, J., Feng, D.-Q., Chen, X.-M., Zhang, H.-B., & Wang, X.-Z. (2012) · Onkologie · doi:10.1159/000338941 · Cited by 53
Xiao, Z., Ko, H. L., Goh, E. H., Wang, B., & Ren, E. C. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt085 · Cited by 53
Che, X., Yang, D., Zong, H., Wang, J., Li, X., Chen, F., Chen, X., & Song, X. (2011) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2010.12.016 · Cited by 51
hnRNP A1 regulates UV-induced NF-κB signalling through destabilization of cIAP1 mRNA
Zhao, T. T., Graber, T. E., Jordan, L. E., Cloutier, M., Lewis, S. M., Goulet, I., Côté, J., & Holčík, M. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.146 · Cited by 49
Clinico-pathologic relevance of Survivin splice variant expression in cancer
de Necochea-Campion, R., Chen, C.-S., Mirshahidi, S., Howard, F. D., & Wall, N. R. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.06.007 · Cited by 47
Splice isoforms as therapeutic targets for colorectal cancer
Miura, K., Fujibuchi, W., & Unno, M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs347 · Cited by 46
Lindenboim, L., Borner, C., & Stein, R. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400888 · Cited by 45
Decreased Expression of SRSF2 Splicing Factor Inhibits Apoptotic Pathways in Renal Cancer
Kędzierska, H., Popławski, P., Hoser, G., Rybicka, B., Rodzik, K., Sokół, E., Bogusławska, J., Tański, Z., Fogtman, A., Koblowska, M., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101598 · Cited by 45
Self-citationLu, G., Liu, S., Huang, S., Chang, Y., & Lin, W. (2014) · Biochimie · doi:10.1016/j.biochi.2014.08.013 · Cited by 41
hnRNP A1 contacts exon 5 to promote exon 6 inclusion of apoptotic Fas gene
Oh, H. K., Lee, E., Jang, H. N., Lee, J., Moon, H., Sheng, Z., Jun, Y., Loh, T. J., Cho, S., Zhou, J., et al. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0824-8 · Cited by 39
Juan, W. C., Roca, X., & Ong, S. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095210 · Cited by 38
Exon 9 skipping of apoptotic caspase-2 pre-mRNA is promoted by SRSF3 through interaction with exon 8
Jang, H. N., Lee, M., Loh, T. J., Choi, S.-W., Oh, H. K., Moon, H., Cho, S., Hong, S.-E., Kim, D. H., Sheng, Z., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.11.006 · Cited by 34
Gao, F., Wu, Y., Zhao, M. L., Liu, C., Wang, L., & Chen, G. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.09.005 · Cited by 34
Lai, F., Jiang, C. C., Farrelly, M. L., Zhang, X. D., & Hersey, P. (2012) · Melanoma Research · doi:10.1097/cmr.0b013e328353eff2 · Cited by 33
Solomon, H., Sharon, M., & Rotter, V. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.99 · Cited by 31
Conney, A. H., Kramata, P., Lou, Y.-R., & Lu, Y. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2007.00263.x · Cited by 29
Sun, F., Han, D., Cao, B., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-4180-x · Cited by 25
Stress-Induced Alternative Splice Forms of MDM2 and MDMX Modulate the p53-Pathway in Distinct Ways
Jacob, A. G., Singh, R. K., Comiskey, D. F., Rouhier, M. F., Mohammad, F., Bebee, T. W., & Chandler, D. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104444 · Cited by 25
Pesson, M., Eymin, B., de la Grange, P., Simon, B., & Corcos, L. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-9 · Cited by 15
Ageichik, A. V., Samejima, K., Kaufmann, S. H., & Earnshaw, W. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704307200 · Cited by 13
Han, J., Tang, F.-M., Pu, D., Xu, D., Wang, T., & Li, W. (2014) · Tumori Journal · doi:10.1177/1430.15824 · Cited by 7
Alternative Pre-mRNA Splicing, Cell Death, and Cancer
Ruirui, K., Ray, P., Yang, M., Wen, P., Zhu, L., Liu, J., Fushimi, K., Kar, A. N., Liu, Y. M., He, R., et al. (2013) · Cancer treatment and research · doi:10.1007/978-3-642-31659-3_8 · Cited by 5
Cited by
Alternative splicing and related RNA binding proteins in human health and disease
Tao, Y., Zhang, Q., Wang, H., Yang, X., & Mu, H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01734-2 · Cited by 320
Quantitative Proteomics Identifies Proteins Enriched in Large and Small Extracellular Vesicles
Lischnig, A., Bergqvist, M., Ochiya, T., & Lässer, C. (2022) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2022.100273 · Cited by 189
Metadata
- Authors
- Kędzierska, H., & Piekiełko-Witkowska, A.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 396
- Pages
- 53-65
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2600528227
- Cited by
- 262
- References
- 160
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.